Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

LFCRLFCR
31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in LIFECORE BIOMEDICAL INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 87,650 shares of LFCR (LIFECORE BIOMEDICAL INC), worth $460,163 as of 2026-Q2. The position was increased (+9.6% shares). LFCR represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$460,163

Current Shares

87,650

Total Value Change

-$1.3M

Total Shares Change

-64,340

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
87,650
+9.6%
$460,1630.0%$5.25
26
2026-Q1
Decreased
79,978
-8.8%
$297,5180.0%$6.99
0
2025-Q4
Increased
87,713
+0.0%
$717,4920.0%$8.09
25
2025-Q3
Decreased
87,687
0.0%
$645,3760.0%$7.15
0
2025-Q2
Increased
87,690
+10.3%
$712,0430.0%$8.19
27
2025-Q1
Increased
79,495
+6.8%
$559,6450.0%$6.85
26
2024-Q4
Increased
74,427
+23.0%
$552,9930.0%$7.42
29
2024-Q3
Unchanged
60,505
0.0%
$298,2900.0%$4.95
0
2024-Q2
Increased
60,505
+480.3%
$310,3910.0%$5.13
38
2024-Q1
Unchanged
10,427
0.0%
$55,3670.0%$5.31
0
2023-Q4
Unchanged
10,427
0.0%
$64,5430.0%$6.19
0
2023-Q3
Unchanged
10,427
0.0%
$78,6720.0%$7.55
0
2023-Q2
Decreased
10,427
-85.1%
$100,8290.0%$9.84
0
2023-Q1
Unchanged
69,828
0.0%
$263,6010.0%$3.79
0
2022-Q4
Increased
69,828
+2.7%
$452,4850.0%$6.48
25
2022-Q3
Increased
67,992
0.0%
$605,0000.0%$8.89
24
2022-Q2
Decreased
67,991
-0.3%
$678,0000.0%$10.06
0
2022-Q1
Increased
68,190
+2.8%
$790,0000.0%$11.42
25
2021-Q4
Unchanged
66,364
0.0%
$737,0000.0%$11.03
0
2021-Q3
Decreased
66,364
-62.7%
$612,0000.0%$10.28
0
2021-Q2
Increased
177,895
+2.9%
$2M0.0%$10.95
27
2021-Q1
Increased
172,838
+3.1%
$1.8M0.0%$10.55
27
2020-Q4
Decreased
167,664
-2.0%
$1.8M0.0%$10.60
0
2020-Q3
Decreased
171,077
-8.2%
$1.7M0.0%$9.68
0
2020-Q2
Increased
186,401
+8.3%
$1.5M0.0%$9.80
28
2020-Q1
Increased
172,144
+1.3%
$1.5M0.0%$8.47
26
2019-Q4
Increased
169,865
+3.6%
$1.9M0.0%$11.17
27
2019-Q3
Increased
164,002
+2.8%
$1.8M0.0%$10.65
26
2019-Q2
Increased
159,516
+3.1%
$1.5M0.0%$9.37
26
2019-Q1
Increased
154,756
+1.8%
$1.9M0.0%$12.28
26
2018-Q4
New
151,990
-
$1.8M0.0%$11.71
36

Other major holders of LFCR: BNP PARIBAS FINANCIAL MARKETS, Russell Investments Group, Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used